|Last Price||Today's Change||52-Week Range||Trading Volume|
|59.72||0.34 (+0.57%)||47.61 - 61.33||3.3 million|
Market data as of 11:37AM 11/21/14. Quotes are delayed by at least 15 min.
VYTORIN® (ezetimibe/simvastatin) Significantly Reduced Cardiovascular Events More than Simvastatin Alone in Patients Presenting with Acute Coronary Syndromes in the Investigational IMPROVE-IT Study
11/17/2014 11:45 AM ET